Dr Olivia Ahn, founder of FLUUS The FemTech industry is rapidly innovating, but the conversation often neglects a fundamental issue: material safety. While we focus on...
High street clinics offering pregnancy scans could be putting unborn babies and their mothers in danger through a lack of properly trained staff, UK experts warn....
The FDA has approved elinzanetant, a new non-hormonal treatment for menopause that reduces hot flushes and night sweats. Clinical trials in the US, Europe and Israel...
Bayer has received US approval for its non-hormonal drug to relieve hot flushes linked to menopause. The US Food and Drug Administration (FDA) has approved Lynkuet...
By Melissa Wallace, CEO & Founding Partner of Fierce Foundry Just a few years ago, so many conversations around women’s health in the U.S. felt like...
London-based women’s health platform SheMed has raised €43m to expand its UK operations and further develop its personalised healthcare platform. The company, founded by sisters Olivia...
Private equity firms Blackstone and TPG will acquire femtech firm Hologic for US$18.3bn, delisting the women’s health diagnostics group if regulators approve the deal. Hologic, known...
By Dr. Jennifer L. Payne and Alisa Marie Beyer Postpartum depression (PPD) isn’t just the “baby blues.” It’s the most common complication of childbirth, affecting 1 in 5...
TIME Magazine has published its Best Inventions of 2025, spotlighting 300 innovations making the world a better place. Femtech World spoke to some of those addressing...
By James Jackson, CEO at Digostics Gestational diabetes (GDM) is one of the most under-recognised challenges in maternity care today. Despite affecting around one in five...
